Nifty

:

18633.95

Sensex

:

62920.87

35.30 (0.19%)
74.49 (0.12%)

Login

Nifty
Sensex

:
:

18633.95
62920.87

35.30 (0.19%)
74.49 (0.12%)

Divi's Laboratories Ltd.

Pharmaceuticals & Drugs - API

Rating :

55/99

BSE: 532488 | NSE: DIVISLAB

Watchlist

NSE BSE

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

92,352.54
50.65
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

89,533.66
0.86%
7.23

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

15.37
18.15
18.43

EBITDA CAGR (%)

10 Years
5 Years
3 Years

16.88
25.18
16.31

PAT CAGR (%)

10 Years
5 Years
3 Years

17.27
27.55
29.08

P:E (Median)

8 Years
5 Years
3 Years

33.94
44.53
49.39

P:BV (Average)

8 Years
5 Years
3 Years

7.80
8.73
10.12

EV:EBITDA (Average)

8 Years
5 Years
3 Years

25.67
29.69
32.26

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 1,908.17 2,495.03 -23.52% 1,689.83 2,466.77 -31.50% 1,823.38 1,967.86 -7.34% 2,203.92 1,950.16 13.01%
Expenses 1,419.47 1,399.06 1.46% 1,280.41 1,366.87 -6.33% 1,214.12 1,149.27 5.64% 1,366.34 1,098.69 24.36%
EBITDA 488.70 1,095.97 -55.41% 409.42 1,099.90 -62.78% 609.26 818.59 -25.57% 837.58 851.47 -1.63%
EBIDTM 25.61% 43.93% 24.23% 44.59% 33.41% 41.60% 38.00% 43.66%
Other Income 66.15 50.51 30.96% 116.34 16.62 600.00% 79.25 19.11 314.70% 89.99 35.55 153.14%
Interest 0.18 0.04 350.00% 0.11 0.20 -45.00% 0.13 0.17 -23.53% 0.10 0.24 -58.33%
Depreciation 86.63 80.75 7.28% 86.54 79.70 8.58% 85.48 77.09 10.88% 83.42 73.01 14.26%
PBT 468.04 1,065.69 -56.08% 439.11 1,036.62 -57.64% 602.90 760.44 -20.72% 844.05 813.77 3.72%
Tax 149.25 182.73 -18.32% 128.21 129.40 -0.92% 116.05 154.05 -24.67% 152.44 261.80 -41.77%
PAT 318.79 882.96 -63.90% 310.90 907.22 -65.73% 486.85 606.39 -19.71% 691.61 551.97 25.30%
PATM 16.71% 35.39% 18.40% 36.78% 26.70% 30.81% 31.38% 28.30%
EPS 12.01 33.26 -63.89% 11.71 34.17 -65.73% 18.34 22.84 -19.70% 26.05 20.79 25.30%

Description Mar 23 Mar 22 Var% Dec 22 Dec 21 Var% Sep 22 Sep 21 Var% Jun 22 Jun 21 Var%
Net Sales 1,950.77 2,518.44 -22.54% 1,707.68 2,493.24 -31.51% 1,854.54 1,987.51 -6.69% 2,254.52 1,960.64 14.99%
Expenses 1,463.18 1,414.02 3.48% 1,299.40 1,396.06 -6.92% 1,233.50 1,169.44 5.48% 1,407.82 1,108.59 26.99%
EBITDA 487.59 1,104.42 -55.85% 408.28 1,097.18 -62.79% 621.04 818.07 -24.08% 846.70 852.05 -0.63%
EBIDTM 24.99% 43.85% 23.91% 44.01% 33.49% 41.16% 37.56% 43.46%
Other Income 66.15 52.39 26.26% 114.25 16.62 587.42% 80.08 19.11 319.05% 88.39 35.97 145.73%
Interest 0.24 0.08 200.00% 0.13 0.23 -43.48% 0.17 0.21 -19.05% 0.13 0.28 -53.57%
Depreciation 87.02 80.99 7.45% 86.77 79.91 8.58% 85.73 77.35 10.83% 83.66 73.26 14.20%
PBT 466.48 1,075.74 -56.64% 435.63 1,033.66 -57.86% 615.22 759.62 -19.01% 851.30 814.48 4.52%
Tax 145.51 181.10 -19.65% 128.83 131.42 -1.97% 121.62 153.16 -20.59% 149.29 257.37 -41.99%
PAT 320.97 894.64 -64.12% 306.80 902.24 -66.00% 493.60 606.46 -18.61% 702.01 557.11 26.01%
PATM 16.45% 35.52% 17.97% 36.19% 26.62% 30.51% 31.14% 28.41%
EPS 12.09 33.70 -64.12% 11.56 33.99 -65.99% 18.59 22.85 -18.64% 26.45 20.99 26.01%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 7,625.30 8,879.82 6,798.61 5,310.57 4,879.66 3,815.94 4,023.85 3,721.33 3,084.01 2,513.97 2,128.89 Net Sales Growth -14.13% 30.61% 28.02% 8.83% 27.88% -5.17% 8.13% 20.67% 22.67% 18.09% Cost Of Goods Sold 3,029.65 2,989.80 2,265.50 2,088.56 1,837.83 1,504.90 1,541.58 1,495.70 1,215.44 918.14 797.66 Gross Profit 4,595.65 5,890.02 4,533.11 3,222.01 3,041.83 2,311.04 2,482.27 2,225.62 1,868.57 1,595.82 1,331.23 GP Margin 60.27% 66.33% 66.68% 60.67% 62.34% 60.56% 61.69% 59.81% 60.59% 63.48% 62.53% Total Expenditure 5,280.34 5,005.05 3,977.73 3,494.16 3,029.59 2,564.33 2,584.97 2,319.91 1,920.97 1,494.24 1,306.36 Power & Fuel Cost - 390.05 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.39% 4.69% 5.29% 5.10% 5.99% 4.94% 4.85% 5.54% 5.86% 6.15% Employee Cost - 926.55 808.68 608.36 530.72 446.27 490.33 352.95 283.15 225.43 191.20 % Of Sales - 10.43% 11.89% 11.46% 10.88% 11.69% 12.19% 9.48% 9.18% 8.97% 8.98% Manufacturing Exp. - 336.15 269.24 238.06 189.32 169.16 155.91 159.65 134.82 110.93 96.90 % Of Sales - 3.79% 3.96% 4.48% 3.88% 4.43% 3.87% 4.29% 4.37% 4.41% 4.55% General & Admin Exp. - 211.22 166.34 135.34 97.56 133.03 79.49 67.41 58.68 46.15 40.67 % Of Sales - 2.38% 2.45% 2.55% 2.00% 3.49% 1.98% 1.81% 1.90% 1.84% 1.91% Selling & Distn. Exp. - 107.56 110.21 75.11 62.51 58.37 59.82 50.37 45.83 39.64 47.70 % Of Sales - 1.21% 1.62% 1.41% 1.28% 1.53% 1.49% 1.35% 1.49% 1.58% 2.24% Miscellaneous Exp. - 43.72 38.61 68.00 62.87 23.87 59.04 13.48 12.23 6.55 47.70 % Of Sales - 0.49% 0.57% 1.28% 1.29% 0.63% 1.47% 0.36% 0.40% 0.26% 0.06% EBITDA 2,344.96 3,874.77 2,820.88 1,816.41 1,850.07 1,251.61 1,438.88 1,401.42 1,163.04 1,019.73 822.53 EBITDA Margin 30.75% 43.64% 41.49% 34.20% 37.91% 32.80% 35.76% 37.66% 37.71% 40.56% 38.64% Other Income 351.73 114.03 63.45 189.86 156.58 112.48 75.94 95.92 42.84 83.90 48.51 Interest 0.52 1.73 1.81 7.03 4.61 2.31 3.33 3.94 2.85 2.93 2.56 Depreciation 342.07 310.55 254.65 185.95 168.81 142.42 123.26 118.10 135.85 92.06 76.90 PBT 2,354.10 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Tax 545.95 727.98 673.15 440.58 500.58 349.78 334.96 264.45 220.12 216.92 180.16 Tax Rate 23.19% 19.80% 25.62% 24.30% 27.31% 28.69% 24.13% 19.23% 20.63% 21.51% 22.76% PAT 1,808.15 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 PAT before Minority Interest 1,808.15 2,948.54 1,954.72 1,372.71 1,332.65 869.58 1,053.27 1,110.84 847.06 791.72 611.42 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.71% 33.20% 28.75% 25.85% 27.31% 22.79% 26.18% 29.85% 27.47% 31.49% 28.72% PAT Growth -38.68% 50.84% 42.40% 3.01% 53.25% -17.44% -5.18% 31.14% 6.99% 29.49% EPS 68.10 111.06 73.62 51.70 50.19 32.75 39.67 41.84 31.90 29.82 23.03

Description TTM Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Net Sales 7,767.51 8,959.83 6,969.40 5,394.42 4,946.26 3,891.49 4,064.34 3,776.36 3,114.94 2,532.14 2,144.84 Net Sales Growth -13.31% 28.56% 29.20% 9.06% 27.10% -4.25% 7.63% 21.23% 23.02% 18.06% Cost Of Goods Sold 3,053.72 2,967.14 2,324.08 2,108.54 1,825.22 1,534.06 1,534.00 1,505.32 1,213.24 914.15 798.63 Gross Profit 4,713.79 5,992.69 4,645.32 3,285.88 3,121.04 2,357.43 2,530.34 2,271.04 1,901.70 1,617.99 1,346.21 GP Margin 60.69% 66.88% 66.65% 60.91% 63.10% 60.58% 62.26% 60.14% 61.05% 63.90% 62.77% Total Expenditure 5,403.90 5,078.72 4,108.34 3,571.21 3,073.24 2,628.74 2,617.20 2,358.04 1,948.69 1,516.76 1,328.87 Power & Fuel Cost - 392.33 319.15 280.73 248.78 228.73 198.80 180.34 170.82 147.40 131.02 % Of Sales - 4.38% 4.58% 5.20% 5.03% 5.88% 4.89% 4.78% 5.48% 5.82% 6.11% Employee Cost - 946.16 825.76 621.05 542.27 456.06 499.90 361.19 290.42 232.46 197.72 % Of Sales - 10.56% 11.85% 11.51% 10.96% 11.72% 12.30% 9.56% 9.32% 9.18% 9.22% Manufacturing Exp. - 365.92 297.84 258.91 212.96 182.67 169.15 169.42 147.24 121.10 104.85 % Of Sales - 4.08% 4.27% 4.80% 4.31% 4.69% 4.16% 4.49% 4.73% 4.78% 4.89% General & Admin Exp. - 236.44 175.26 148.62 105.30 139.33 88.22 73.91 63.85 51.74 44.15 % Of Sales - 2.64% 2.51% 2.76% 2.13% 3.58% 2.17% 1.96% 2.05% 2.04% 2.06% Selling & Distn. Exp. - 127.01 124.03 85.36 73.08 64.02 67.48 56.04 51.93 44.22 51.29 % Of Sales - 1.42% 1.78% 1.58% 1.48% 1.65% 1.66% 1.48% 1.67% 1.75% 2.39% Miscellaneous Exp. - 43.72 42.22 68.00 65.63 23.87 59.65 11.80 11.18 5.69 51.29 % Of Sales - 0.49% 0.61% 1.26% 1.33% 0.61% 1.47% 0.31% 0.36% 0.22% 0.06% EBITDA 2,363.61 3,881.11 2,861.06 1,823.21 1,873.02 1,262.75 1,447.14 1,418.32 1,166.25 1,015.38 815.97 EBITDA Margin 30.43% 43.32% 41.05% 33.80% 37.87% 32.45% 35.61% 37.56% 37.44% 40.10% 38.04% Other Income 348.87 115.90 62.67 189.63 155.63 113.44 74.89 97.44 44.70 70.60 44.81 Interest 0.67 2.00 2.10 7.14 4.68 2.37 3.36 4.74 2.88 2.96 2.59 Depreciation 343.18 311.51 255.59 186.24 168.90 142.49 123.33 118.18 136.00 92.12 76.95 PBT 2,368.63 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Tax 545.25 723.05 681.75 442.92 502.33 354.32 334.92 267.06 220.56 217.58 179.23 Tax Rate 23.02% 19.63% 25.57% 24.34% 27.08% 28.78% 24.00% 19.17% 20.57% 21.96% 22.94% PAT 1,823.38 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 PAT before Minority Interest 1,823.38 2,960.45 1,984.29 1,376.54 1,352.74 877.01 1,060.42 1,125.78 851.52 773.34 602.01 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 23.47% 33.04% 28.47% 25.52% 27.35% 22.54% 26.09% 29.81% 27.34% 30.54% 28.07% PAT Growth -38.41% 49.19% 44.15% 1.76% 54.24% -17.30% -5.81% 32.21% 10.11% 28.46% EPS 68.68 111.50 74.74 51.85 50.95 33.03 39.94 42.40 32.07 29.13 22.67

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,691.35 9,271.57 7,316.69 6,973.31 5,959.65 5,408.91 4,357.04 3,561.96 3,034.42 2,553.28 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,638.26 9,218.48 7,263.60 6,920.22 5,906.56 5,355.82 4,303.95 3,535.41 3,007.87 2,526.73 Non-Current Liabilities 448.11 363.48 294.48 993.72 1,769.95 1,418.95 92.33 847.80 656.71 477.08 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,427.29 1,704.78 1,796.64 832.52 640.49 655.84 516.12 772.32 623.14 551.59 Trade Payables 771.30 748.78 580.34 483.31 405.65 442.30 230.42 224.38 148.69 158.31 Other Current Liabilities 392.95 337.25 286.51 242.50 170.79 176.52 239.46 202.73 146.55 129.35 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,263.04 618.40 896.16 1.11 0.94 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.27 3,581.95 Net Block 4,320.97 3,699.01 2,776.26 2,087.44 1,995.88 1,558.95 1,438.64 1,308.73 1,221.60 908.50 Gross Block 5,617.69 4,685.46 3,508.06 2,633.29 2,372.92 1,793.57 2,195.42 1,952.40 1,739.79 1,337.88 Accumulated Depreciation 1,296.72 986.45 731.80 545.85 377.04 234.62 756.78 643.67 518.19 429.38 Non Current Assets 5,011.90 4,598.63 3,852.94 4,152.06 3,816.18 3,444.55 1,907.39 2,386.10 2,034.87 1,708.04 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 79.37 7.37 7.37 554.62 7.37 8.37 10.19 2.82 2.82 2.82 Long Term Loans & Adv. 133.58 172.42 144.18 1,012.93 1,688.04 1,424.88 188.87 856.03 665.87 493.23 Other Non Current Assets 8.05 9.21 5.44 5.16 5.13 8.78 5.78 0.35 0.09 0.07 Current Assets 9,554.85 6,741.20 5,554.87 4,647.49 4,553.91 4,039.15 3,058.10 2,795.98 2,279.41 1,873.91 Current Investments 0.00 0.00 971.35 1,398.34 1,889.29 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,644.05 2,042.70 1,744.17 1,663.18 1,281.39 1,255.76 1,162.89 1,114.90 893.27 805.95 Sundry Debtors 2,569.90 1,745.56 1,533.21 1,282.24 1,112.11 1,002.89 966.12 823.03 791.64 558.90 Cash & Bank 2,803.68 2,142.01 107.36 105.20 91.48 66.47 59.38 56.66 35.77 34.68 Other Current Assets 1,537.22 51.63 48.63 11.56 179.64 83.31 66.86 68.39 56.86 66.56 Short Term Loans & Adv. 1,507.86 759.30 1,150.15 186.97 160.15 63.14 48.19 54.14 47.56 57.28 Net Current Assets 7,127.56 5,036.42 3,758.23 3,814.97 3,913.42 3,383.31 2,541.98 2,023.66 1,656.26 1,322.32 Total Assets 14,566.75 11,339.83 9,407.81 8,799.55 8,370.09 7,483.70 4,965.49 5,182.08 4,314.28 3,581.95

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Shareholder's Funds 11,728.18 9,294.61 7,309.92 6,957.15 5,924.80 5,357.39 4,293.31 3,495.36 2,963.35 2,500.60 Share Capital 53.09 53.09 53.09 53.09 53.09 53.09 53.09 26.55 26.55 26.55 Total Reserves 11,675.09 9,241.52 7,256.83 6,904.06 5,871.71 5,304.30 4,240.21 3,468.81 2,936.80 2,474.05 Non-Current Liabilities 436.51 363.94 294.57 991.38 1,768.91 1,411.75 85.17 841.57 650.05 469.75 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.47 1.05 1.55 2.10 Long Term Provisions 26.71 25.42 20.52 772.54 1,577.26 1,288.92 11.57 714.30 533.49 388.43 Current Liabilities 2,454.44 1,728.35 1,820.53 846.75 653.42 659.45 519.50 775.53 627.41 554.45 Trade Payables 795.70 763.20 590.72 492.26 411.21 445.80 232.69 226.87 151.70 160.44 Other Current Liabilities 394.02 340.42 290.09 243.59 175.46 176.63 240.58 203.45 147.80 130.08 Short Term Borrowings 0.00 0.35 33.63 105.60 63.11 35.74 41.42 25.07 16.32 30.51 Short Term Provisions 1,264.72 624.38 906.09 5.30 3.64 1.28 4.81 320.14 311.58 233.42 Total Liabilities 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.98 5,112.46 4,240.81 3,524.80 Net Block 4,325.05 3,703.87 2,781.85 2,087.77 1,996.19 1,559.19 1,438.77 1,308.89 1,221.84 908.72 Gross Block 5,624.27 4,691.86 3,514.25 2,633.93 2,373.45 1,793.95 2,196.08 1,953.02 1,740.34 1,338.35 Accumulated Depreciation 1,299.22 987.99 732.40 546.16 377.26 234.76 757.32 644.13 518.50 429.63 Non Current Assets 5,008.74 4,596.30 3,851.49 4,145.23 3,812.01 3,418.08 1,870.93 2,340.06 1,984.45 1,660.69 Capital Work in Progress 469.93 710.62 919.69 491.91 119.76 443.57 263.91 218.18 144.48 303.41 Non Current Investment 72.01 0.01 0.01 547.26 0.01 0.01 0.01 0.00 0.00 0.00 Long Term Loans & Adv. 133.70 172.59 144.50 1,012.93 1,688.23 1,406.48 162.44 812.63 618.03 448.49 Other Non Current Assets 8.05 9.21 5.44 5.36 7.82 8.83 5.80 0.35 0.09 0.07 Current Assets 9,610.39 6,790.60 5,573.53 4,650.05 4,535.12 4,010.51 3,027.04 2,772.40 2,256.35 1,864.11 Current Investments 0.00 0.00 971.35 1,398.34 1,889.28 1,630.72 802.85 733.00 501.88 407.81 Inventories 2,828.62 2,145.23 1,863.86 1,772.34 1,350.67 1,319.91 1,207.83 1,162.64 932.42 835.69 Sundry Debtors 2,423.88 1,676.52 1,413.35 1,163.37 1,014.36 900.92 880.92 741.64 723.70 512.00 Cash & Bank 2,818.88 2,156.03 122.63 115.26 112.46 78.70 73.43 65.22 40.51 40.89 Other Current Assets 1,539.01 51.95 52.16 142.20 168.35 80.26 62.01 69.89 57.85 67.71 Short Term Loans & Adv. 1,509.32 760.87 1,150.18 58.54 43.37 59.59 42.88 54.98 48.16 57.97 Net Current Assets 7,155.95 5,062.25 3,753.00 3,803.30 3,881.70 3,351.06 2,507.54 1,996.87 1,628.95 1,309.66 Total Assets 14,619.13 11,386.90 9,425.02 8,795.28 8,347.13 7,428.59 4,897.97 5,112.46 4,240.80 3,524.80

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,910.16 1,947.05 1,208.47 964.06 764.72 1,149.11 1,036.34 822.44 558.15 482.83 PBT 3,676.52 2,627.87 1,813.29 1,833.23 1,219.36 1,388.23 1,375.29 1,067.18 1,008.64 791.58 Adjustment 235.32 186.66 52.55 86.71 29.72 81.10 69.27 108.33 70.06 55.01 Changes in Working Capital -1,371.89 -234.52 -211.40 -472.96 -215.81 -18.52 -147.34 -141.64 -307.22 -189.31 Cash after chg. in Working capital 2,539.95 2,580.01 1,654.44 1,446.98 1,033.27 1,450.81 1,297.23 1,033.87 771.48 657.29 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -629.79 -632.96 -445.97 -482.92 -268.55 -301.70 -260.89 -211.43 -213.34 -174.46 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,195.40 75.34 -81.38 -684.24 -475.89 -1,137.41 -411.16 -520.77 -305.08 -254.49 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.86 72.32 246.93 4.58 37.22 -533.55 -45.19 -3.34 31.97 44.36 Cash from Financing Activity -531.50 -33.97 -1,091.25 -245.94 -314.17 3.27 -630.34 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -816.74 1,988.42 35.84 33.88 -25.34 14.97 -5.17 -1.28 4.57 -2.43 Opening Cash & Equivalents 2,016.30 27.88 -7.96 -41.84 -16.50 -31.47 9.06 10.35 5.78 8.20 Closing Cash & Equivalent 1,199.56 2,016.30 27.88 -7.96 -41.84 -16.50 3.89 9.06 10.35 5.78

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Cash From Operating Activity 1,911.80 1,946.93 1,215.94 954.30 775.86 1,150.37 1,037.86 826.33 556.75 479.97 PBT 3,683.50 2,666.04 1,819.46 1,855.07 1,231.33 1,395.34 1,392.84 1,072.08 990.92 781.24 Adjustment 239.73 189.29 60.01 83.51 32.19 93.87 60.94 91.24 77.55 59.25 Changes in Working Capital -1,370.45 -264.08 -218.30 -499.84 -219.11 -37.14 -155.03 -125.55 -298.39 -186.05 Cash after chg. in Working capital 2,552.78 2,591.25 1,661.17 1,438.74 1,044.41 1,452.07 1,298.75 1,037.76 770.07 654.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -640.98 -644.32 -445.23 -484.44 -268.55 -301.70 -260.89 -211.43 -213.32 -174.47 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -2,194.92 75.13 -83.47 -685.40 -478.30 -1,139.60 -406.41 -520.84 -305.15 -254.54 Net Fixed Assets -691.54 -968.33 -1,302.55 -632.52 -255.54 222.19 -288.75 -286.31 -242.98 -368.08 Net Investments -72.00 971.35 974.24 -56.30 -257.57 -826.05 -77.22 -231.12 -94.07 69.23 Others -1,431.38 72.11 244.84 3.42 34.81 -535.74 -40.44 -3.41 31.90 44.31 Cash from Financing Activity -532.44 -34.89 -1,091.42 -245.94 -314.16 2.38 -631.12 -302.95 -248.50 -230.76 Net Cash Inflow / Outflow -815.56 1,987.17 41.05 22.96 -16.60 13.15 0.33 2.54 3.10 -5.33 Opening Cash & Equivalents 2,030.32 43.15 2.10 -20.86 -4.26 -17.41 17.62 15.09 11.99 17.32 Closing Cash & Equivalent 1,214.76 2,030.32 43.15 2.10 -20.86 -4.26 17.95 17.62 15.09 11.99

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 440.44 349.28 275.63 262.70 224.51 203.76 164.13 134.18 114.30 96.18 ROA 22.76% 18.84% 15.08% 15.52% 10.97% 16.92% 21.89% 17.84% 20.05% 19.15% ROE 28.13% 23.57% 19.21% 20.61% 15.30% 21.57% 28.06% 25.68% 28.34% 25.86% ROCE 35.09% 31.64% 25.23% 28.06% 21.31% 28.27% 34.53% 32.22% 35.88% 32.98% Fixed Asset Turnover 1.73 1.66 1.75 1.95 1.84 2.04 1.81 1.69 1.65 1.77 Receivable days 88.26 87.73 95.70 89.55 100.59 88.38 87.08 94.72 97.33 93.02 Inventory Days 95.85 101.33 115.82 110.13 120.67 108.57 110.86 117.81 122.46 124.00 Payable days 92.79 107.07 92.94 52.95 60.35 47.52 35.14 33.59 36.19 42.55 Cash Conversion Cycle 91.32 81.99 118.58 146.72 160.91 149.43 162.79 178.93 183.60 174.46 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 2126.16 1452.86 258.94 398.66 528.86 417.89 349.89 375.24 345.75 310.56

Description Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13
Book Value (Rs.) 441.82 350.15 275.38 262.09 223.20 201.82 161.73 131.67 111.63 94.20 ROA 22.77% 19.07% 15.11% 15.78% 11.12% 17.21% 22.49% 18.21% 19.92% 19.17% ROE 28.16% 23.90% 19.30% 21.00% 15.55% 21.98% 28.91% 26.37% 28.31% 25.99% ROCE 35.06% 32.07% 25.36% 28.50% 21.68% 28.75% 35.57% 33.06% 36.04% 33.21% Fixed Asset Turnover 1.74 1.70 1.77 1.98 1.88 2.06 1.83 1.70 1.66 1.78 Receivable days 83.26 80.66 86.18 80.35 89.33 79.19 77.83 85.12 88.42 85.08 Inventory Days 100.99 104.66 121.62 115.23 124.56 112.34 113.70 121.69 126.52 127.96 Payable days 95.88 106.32 93.73 52.21 60.15 47.14 35.06 33.55 36.16 42.47 Cash Conversion Cycle 88.36 79.00 114.07 143.37 153.75 144.39 156.47 173.26 178.78 170.58 Total Debt/Equity 0.00 0.00 0.00 0.02 0.01 0.01 0.01 0.01 0.01 0.01 Interest Cover 1842.75 1270.54 255.83 397.38 520.55 416.28 294.75 373.59 336.24 302.96

Top Investors:

sbi mutual fund

life insurance corporation of india

axis mutual fund trustee limited

government pension fund global

investor education and protection fund (iepf)

Annual Reports:

News Update:

Divi's Laboratories reports 64% fall in Q4 consolidated net profit
22nd May 2023, 12:44 PM

Total consolidated income of the company decreased by 21.55% at Rs 2,016.92 crore for Q4FY23
Read More
Divi's Lab - Quarterly Results
20th May 2023, 13:28 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback